Health Encyclopedia


Health Encyclopedia Home

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study

WEDNESDAY, May 14, 2014 (HealthDay News) -- Hormone-depletion therapy is a common treatment for prostate cancer, but one that also carries side effects for men such as sexual dysfunction and fatigue.

However, a new study suggests that in certain cases the treatment can be delayed -- boosting the patient's quality of life.

Doctors often track blood levels of a tumor-associated protein called prostate-specific antigen (PSA) after prostate cancer surgery or radiation therapy, to gauge whether the cancer is rebounding or not.

In the new study, researchers found that it was safe to delay hormone-depleting therapy in men with rising PSA levels who did not experience symptoms or have evidence of a tumor.

One expert applauded the study. "In view of the cost and potential side effects that are associated with hormonal therapy, this is an important study that supports the notion that we don't have to jump on early hormonal therapy if PSA is showing signs of recurrence," said Dr. Ash Tewari, chair of urology at the Icahn School of Medicine at Mount Sinai, in New York City.

The study was released Wednesday ahead of the annual meeting of the American Society of Clinical Oncology (ASCO), which begins May 30 in Chicago. It will be formally presented at the meeting on June 1.

"Hormone [-depleting] therapy is one of the oldest, most common and most effective treatment approaches in prostate cancer, and these findings will influence the treatment of thousands of patients worldwide," ASCO president-elect Dr. Peter Yu said in a society news release.

"This study is also a great example of how less-aggressive treatment can sometimes offer patients optimal outcomes while sparing them from side effects that impair their quality of life," Yu added.

Natural hormones such as testosterone are known to be associated with the growth of prostate tumors. So, one common treatment, called androgen deprivation therapy, involves reducing a patient's levels of these hormones.

However, ASCO experts note that the therapy also has side effects, including sexual dysfunction, weakening bones, hot flashes, fatigue, decreased mental sharpness, depression and loss of muscle mass, among others.

But what if the therapy could be at least delayed, even if a patient's PSA levels are rising? The new study found that, in certain cases, delaying hormonal therapy in this scenario is possible.

In the study, the researchers looked at data on more than 14,000 patients. Of these, just over 2,000 saw their PSA levels begin to climb again after prostate surgery or radiation therapy. These "PSA relapse" patients were divided into two groups: those who received hormone therapy immediately and those who deferred their hormone therapy until later.

The "immediate" group received hormone-depleting therapy within three months of their PSA relapse. The "deferred" group did not receive it until they developed a tumor or symptoms. Men in the "deferred" group also received hormonal therapy if their PSA level doubled in a short period of time.

Overall, the average time from initial treatment to PSA relapse was a little more than 2 years, the researchers said. After experiencing a relapse, the men were followed for an average of almost 3.5 years.

Waiting longer to begin hormone therapy did not have a significant effect on men's long-term survival, the researchers reported. The estimated five-year survival for the "immediate" treatment group was about 85 percent, compared to just over 87 percent for the "deferred" group -- not a significant difference. The researchers concluded there was no significant benefit to starting hormone therapy right away after a PSA relapse.

Postponing treatment could, however, reduce the side effects and costs linked with hormone therapy. Waiting to begin treatment could give men two or more years of life without some of the common and distressing symptoms tied to the therapy, the researchers suggested.

"Rising PSA levels trigger a lot of anxiety, and many men want to start treatment as soon as possible," study lead author Dr. Xabier Garcia-Albeniz, a research associate at Harvard University School of Public Health in Boston, said in the ASCO news release.

"These findings suggest that there may be no need to rush to androgen deprivation therapy. If our results are confirmed in randomized trials, patients could feel more comfortable waiting until they develop symptoms or signs of cancer that are seen on a scan, before initiating [treatment]," Garcia-Albeniz explained.

However, research presented at medical meetings is typically considered preliminary until published in a peer-reviewed journal, and Tewari agreed that more research will be necessary. "Further studies are needed that can possibly guide us in selecting those who may need early therapy based on high disease burden or lowered body's immune mechanism," he said.

More information

The U.S. National Cancer Institute has more about prostate cancer treatment.

SOURCES: Ash Tewari, M.D., chair in urology, Icahn School of Medicine at Mount Sinai, and chairman, Milton and Carroll Petrie department of urology, Mount Sinai Hospital, New York City; American Society of Clinical Oncologists, news release, May 14, 2014

Related Items
Daily News Feed
  'Low T' Therapy: Is It for Me?
  New Clues About Hot Flashes and the Brain
  Plastics Chemical BPA May Harm Human Fertility: Study
  Typical Pregnancy Length May Vary More Than Thought
  Earlier Acne Outbreaks May Be Caused by Earlier Puberty: Experts
  Talking to Your Daughter About Puberty
  New Drug Shows Promise for Type 2 Diabetes
  Smaller Testicles, Bigger Parenting Role, Study Suggests
  Nearly 60 Percent of Uterine Cancer Cases Preventable: Report
  Testosterone Not the Whole Story in 'Male Menopause'
  'Love Hormone' May Affect Social Connections
  Tamoxifen's Mental Side Effects Are Real, Study Shows
  Low Testosterone Linked to Possible Heart Problems in Men
  Extended Hormone Therapy Doesn't Help Some Prostate Cancer Patients: Study
  New Analysis Confirms Hormone Therapy Won't Prevent Disease After Menopause
  Usual 'Hot Flash' Therapies Don't Help Prostate Cancer Patients: Study
  Daily Walk May Cut Your Breast Cancer Risk
  Multiple Egg Donations May Not Affect Women's Future Fertility: Study
  Extra Shuteye on Weekends May Not Replace Sleep Lost During Week
  Plastics Chemicals Tied to Reproductive Woes for Both Sexes
  After Breast Cancer Surgery, Patient Assistance Programs Can Help
  Thyroid Levels of Older Hospital Patients May Be Linked to Survival
  Childhood Obesity Again Tied to Earlier Puberty in Girls
  Study Raises Questions About Testosterone Therapy
  Estrogen After Menopause May Blunt Stress' Effects on Memory
  Hormone Therapy May Work Only for Women With Hot Flashes
  Time of Month May Affect Women's Concussion Recovery
  Most Men With Breast Cancer Undergo Mastectomy, Study Finds
  Too Much Testosterone May Be Unhealthy for Older Men
  Might Stomach Artery Treatment Be Future Weight-Loss Tool?
  Estrogen Won't Make Women Sharper After Menopause, Study Finds
  How the 'Love Hormone' Works Its Magic
  Bigger Breasts, Lack of Exercise Tied to Breast Cancer Mortality
  Could Water Near Fracking Sites Disrupt Hormones?
  Keep Your Toddler's Body Clock in Mind at Bedtime
  Obese Kids Might Have Higher Levels of Stress Hormone
  Experts Lay Out Options for Menopause Symptoms
  Testosterone May Undermine Flu Shot's Effectiveness for Men
  Hormone Takes the High Out of Weed, Rodent Study Finds
  High Blood Pressure May Be Worse for Women
  Breast-Feeding Might Reduce Moms' Odds of Rheumatoid Arthritis
  Smoking in Pregnancy Tied to Later Nicotine Addiction in Daughters
  Ban on Chemicals Lowers Human Exposures, Study Finds
  'Sleep Hormone' Tied to Possible Lower Prostate Cancer Risk
  Drug May Extend Survival for Men With Advanced Prostate Cancer
  Testosterone Therapy Might Increase Heart Attack Risk: Study
  Postmenopausal Estrogen Therapy Tied to Lower Glaucoma Risk
  FDA Will Review Safety of Testosterone Therapy
  'Fat Hormone' Tied to Higher Colon Cancer Risk in Obese Men
  More Specialists Question Safety of Testosterone Therapy for Older Men
  Ovary Removal Might Raise Odds for Bone Loss, Heart Disease
  Could Stress Hormones Help Spur Stock Market Crashes?
  Cashiers May Absorb Controversial Chemical When Handling Receipts
  Obesity, 'The Pill' May Raise MS Risk, Research Suggests
  Hormones Might Offer Relief From Chronic Pain, Small Study Suggests
  'Low T' Diagnosis Needs More Than a Blood Test, Experts Say
  'Love Hormone' May Help Those With Anorexia
  Does Self-Esteem Affect Seniors' Health?
  Higher Dose of IVF Drug May Be Needed for Obese Women
  Childhood Abuse May Lead to Health Ills in Adulthood
  Toddlers Who Sleep Less May Eat More
  'Grazing' Appears No Better for Weight Loss Than Standard Meals
  Exercise Affects Men's, Women's Hearts Differently: Study
  Could Reducing Stress Help Bring On a Migraine?
  Could Daughter's Cancer Risk Be Affected by Father's Age at Birth?
  Study Ties Antidepressant Use in Pregnancy to Autism Risk in Boys
  Working With Horses May Ease Stress in Kids
  More Evidence Ties Poor Sleep to Obesity in Kids
  Iodine Deficiency Common in Pregnancy, Pediatricians Warn
  Antidepressant Eases Menopause-Related Symptoms, Study Finds
  PMS Not Linked to Hot Flashes Later, Study Finds
  Hormone Levels in Womb Tied to Autism Risk in Boys: Study
  Insulin Use, Out-of-Pocket Costs Way Up for Type 2 Diabetes
  Shortage of Doctors Who Treat Diabetes Looming
  Mouse Study Supports Notion of 'Tanning Addiction'
  Testosterone Products Must Warn About Risk of Venous Clots: FDA
  Latest Study Finds No Link Between Testosterone Supplements, Heart Attack
  Losing Weight May Ease Hot Flashes, Study Finds
  Men With Prostate Cancer May Not Always Get Best Advice
Adult Diseases and Conditions
  Hormones and the Endocrine System
  Hormones During Pregnancy